Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

CENTOGENE’S LATEST SCIENTIFIC PUBLICATIONS & WEBINARS

Cómo los biomarcadores transforman el Diagnóstico Genético

Únase con nosotros el próximo 20 de abril, donde hablaremos sobre la enfermedad de Fabry y…

Webinar with topic Biomarker, Metabolic Disorders
Register

How Biomarkers Transform Genetic Diagnostics

Join us on April 15th as we share insights into Fabry Disease and a biomarker success…

Webinar with topic Biomarker, Metabolic Disorders
Register

A Dispute on Rare Disease Diagnostic Offerings

CENTOGENE was amongst the first providers of diagnostic Whole Genome Sequencing (WGS) and…

Article with topic WGS, Mutation Database
Read more

An Unusual Kind of Repeat Expansion Disorder

Repeat expansions are the cause of Huntington’s disease and several forms of ataxia. The…

Article with topic Neurology, WES, WGS, Mutation Database
Read more

Diagnostic Relevance of Intronic Variants

Proper splicing of mRNA requires certain DNA sequence motifs. Since these motifs are very…

Article with topic Mutation Database, WES, WGS
Read more

Exemplifying the Strengths of Genome Sequencing

Certain genetic variants are easily missed by Exome Sequencing (ES), but readily detected…

Article with topic Neurology, Dysmorphology, WGS, Mutation Database
Read more

Utilization of CentoMD® in Scientific Settings

The interpretation of newly observed genetic variants that are suspected to cause disease…

Article with topic Mutation Database, WES, WGS
Read more

Turning Rare Disease Networks into Knowledge

CENTOGENE’s well-recognized expertise in Gaucher disease (GD) has helped to establish a…

Article with topic Hepatology, Metabolic Disorders, Neurology, Hematology, Biomarker, NGS, Mutation Database
Read more

Genetic Cause of Impaired Neurodevelopment

Development of the nervous system is a complex process, with NEUROG1 being one out of many…

Article with topic Neurology, WES, Mutation Database
Read more

Exemplifying the High Value of CentoMD®

Rare disease research usually focuses on pathogenic genetic variants. The lack of a…

Article with topic Mutation Database
Read more

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CENTOGENE to Announce Full Year 2020 Financial Results on April 15, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 8, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare...

 Read more
Centogene,

CENTOGENE Reaches 10,000 Participant Milestone in Global Parkinson’s Disease Study

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE)

  • Rostock International Parkinson's Disease (ROPAD) Study aims to characterize...
 Read more
Centogene,

CENTOGENE entdeckt bei der Sequenzierung positiver Befunde seltene SARS-CoV-2 Variante B.1.525 erstmals in einer durch das Unternehmen analysierten Probe

ERLÄUTERUNG ZUR PRESSEMITTEILUNG: CENTOGENE ENTDECKT BEI DER SEQUENZIERUNG POSITIVER BEFUNDE SELTENE SARS-COV-2 VARIANTE B.1.525 ERSTMALS IN DEUTSCHLAND

wir...

 Read more
Centogene,

CENTOGENE und die Stadt Rostock starten Pilotprojekt zur sicheren Schulöffnung durch regelmäßige SARS-CoV-2-PCR-Testungen der gesamten Schüler- und Lehrerschaft der Region

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 04. März 2021

  • Ab nächster Woche bis zu den Pfingstferien bietet CENTOGENE den etwa 30.000 Schülern...
 Read more
Centogene,

CENTOGENE führt Studie zur Untersuchung des SARS-CoV-2-Infektionsrisikos im Öffentlichen Personen-Nahverkehr in Zusammenarbeit mit der Charité Research Organisation durch

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 22. Februar 2021

  • Epidemiologische Studie verfolgt das Ziel, das spezifische...
 Read more
Centogene,

Science meets Culture: CENTOGENE Rare Disease Day

Virtuelle Konferenz und -Filmfestival 2021 am 28. Februar 2021

 Read more
Centogene,

Science Meets Culture: CENTOGENE’s Rare Disease Day 2021 Activities

Virtual Conference and Filmfestival on February 28, 2021

 Read more
Centogene,

CENTOGENEs Ergebnisse aus der Sequenzierung weiterer positiver COVID-19 Befunde auf neue SARS-CoV-2 Varianten ergeben neue Variante B.1.258 im Großraum zwischen Kdyne, Frankfurt und München

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 16. Februar 2021

  • Im Zuge der aufgetretenen SARS-CoV-2 Mutationen aus Großbritannien und Südafrika hat...
 Read more
Centogene,

CENTOGENEs Walk-In-Corona-Testzentrum in Rostock zieht in die Innenstadt und erweitert Fläche, Angebot und Öffnungszeiten

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 15. Februar 2021

  • Das Walk-In-Testzentrum an CENTOGENEs Firmenhauptsitz, am Strande 7 in Rostock, wird...
 Read more
Centogene,